Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 12—December 2005

Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum

J. Stephen Dumler*Comments to Author , Kyoung-Seong Choi*, Jose Carlos Garcia-Garcia*, Nicole S. Barat*, Diana G. Scorpio*, Justin W. Garyu*, Dennis J. Grab*, and Johan S. Bakken†‡
Author affiliations: *Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; †University of Minnesota at Duluth, Duluth, Minnesota, USA; ‡St. Luke's Hospital, Duluth, Minnesota, USA

Main Article


Metaanalysis of clinical manifestations and laboratory abnormalities in patients with human granulocytic anaplasmosis*

Characteristics All
North America
Median %† Mean % n‡ Mean % n Mean % n
Symptom or sign
Fever 100 92 480 92 448 98 66
Myalgia 74 77 514 79 448 65 66
Headache 89 75 378 73 289 89 66
Malaise 93 94 90 96 271 47 15
Nausea 44 38 256 36 207 47 49
Vomiting 20 26 90 34 41 19 49
Diarrhea 13 16 90 22 41 10 49
Cough 13 19 260 22 207 10 49
Arthralgias 58 46 497 47 448 37 49
Rash 3 6 685 6 289 4 53
Stiff neck 11 18 22 22 18 0 4
Confusion 9 17 211 17 207 0 4
Laboratory abnormality
Leukopenia 38 49 329 50 282 47 47
Thrombocytopenia 71 71 329 72 282 64 47
Elevated serum AST or ALT§ 74 71 170 79 123 51 47
Elevated serum creatinine 15 43 72 49 59 0 13

*Data from references 5, 6, 815.

†Median percentage of patients with feature among all reports.

‡Number of patients with data available for metaanalysis.

§AST, aspartate aminotransferase; ALT, alanine aminotransferase.

Main Article

  1. Chen  S-M, Dumler  JS, Bakken  JS, Walker  DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 1994;32:58995.PubMedGoogle Scholar
  2. Bakken  JS, Dumler  JS, Chen  SM, Eckman  MR, Van Etta  LL, Walker  DH. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging? JAMA. 1994;272:2128. DOIPubMedGoogle Scholar
  3. Dumler  JS, Barbet  AF, Bekker  CP, Dasch  GA, Palmer  GH, Ray  SC, Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol. 2001;51:214565. DOIPubMedGoogle Scholar
  4. Walker  DH, Dumler  JS. Emergence of ehrlichioses as human health problems. Emerg Infect Dis. 1996;2:1829. DOIPubMedGoogle Scholar
  5. Bakken  JS, Krueth  J, Wilson-Nordskog  C, Tilden  RL, Asanovich  K, Dumler  JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996;275:199205. DOIPubMedGoogle Scholar
  6. Aguero-Rosenfeld  ME, Horowitz  HW, Wormser  GP, McKenna  DF, Nowakowski  J, Munoz  J, Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996;125:9048.PubMedGoogle Scholar
  7. Hardalo  C, Quagliarello  V, Dumler  JS. Human granulocytic ehrlichiosis in Connecticut: report of a fatal cases. Clin Infect Dis. 1995;21:9104. DOIPubMedGoogle Scholar
  8. Lotric-Furlan  S, Petrovec  M, Avsic-Zupanc  T, Strle  F. Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci. 2003;990:27984. DOIPubMedGoogle Scholar
  9. Blanco  JR, Oteo  JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect. 2002;8:76372. DOIPubMedGoogle Scholar
  10. Bjoersdorff  A, Wittesjo  B, Berglun  J, Massung  RF, Eliasson  I. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. Scand J Infect Dis. 2002;34:18791. DOIPubMedGoogle Scholar
  11. Belongia  EA, Gale  CM, Reed  KD, Mitchell  PD, Vandermause  M, Finkel  MF, Population-based incidence of human granulocytic ehrlichiosis in northwestern Wisconsin, 1997–1999. J Infect Dis. 2001;184:14704. DOIPubMedGoogle Scholar
  12. Belongia  EA, Reed  KD, Mitchell  PD, Chyou  PH, Mueller-Rizner  N, Finkel  MF, Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin Infect Dis. 1999;29:14727. DOIPubMedGoogle Scholar
  13. Wallace  BJ, Brady  G, Ackman  DM, Wong  SJ, Jacquette  G, Lloyd  EE, Human granulocytic ehrlichiosis in New York. Arch Intern Med. 1998;158:76973. DOIPubMedGoogle Scholar
  14. Lotric-Furlan  S, Petrovec  M, Avsic-Zupanc  T, Strle  F. Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. Scand J Infect Dis. 2004;36:81722. DOIPubMedGoogle Scholar
  15. Bakken  JS. Clinical diagnosis and treatment of human granulocytic anaplasmosis. In: Abstracts of the 4th International Conference on Rickettsiae and Rickettsial Diseases, Logrono, Spain, 2005 Jun 18–21. Abstract O-34.
  16. Bakken  JS, Goellner  P, Van Etten  M, Boyle  DZ, Swonger  OL, Mattson  S, Seroprevalence of human granulocytic ehrlichiosis (HGE) and risk factors associated with infection among residents in northwestern Wisconsin. Clin Infect Dis. 1998;27:14916. DOIPubMedGoogle Scholar
  17. Aguero-Rosenfeld  ME, Donnarumma  L, Zentmaier  L, Jacob  J, Frey  M, Noto  R, Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol. 2002;40:26125. DOIPubMedGoogle Scholar
  18. IJdo  JW, Meek  JI, Cartter  ML, Magnarelli  LA, Wu  C, Tenuta  SW, The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis. 2000;181:138893. DOIPubMedGoogle Scholar
  19. Lepidi  H, Bunnell  JE, Martin  ME, Madigan  JE, Stuen  S, Dumler  JS. Comparative pathology and immunohistology associated with clinical illness after Ehrlichia phagocytophila–group infections. Am J Trop Med Hyg. 2000;62:2937.PubMedGoogle Scholar
  20. Brodie  TA, Holmes  PH, Urquhart  GM. Some aspects of tick-borne diseases of British sheep. Vet Rec. 1986;118:4158. DOIPubMedGoogle Scholar
  21. Gribble  DH. Equine ehrlichiosis. J Am Vet Med Assoc. 1969;155:4629.PubMedGoogle Scholar
  22. Lin  M, Rikihisa  Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun. 2003;71:532431. DOIPubMedGoogle Scholar
  23. Ohashi  N, Zhi  N, Lin  Q, Rikihisa  Y. Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect Immun. 2002;70:212838. DOIPubMedGoogle Scholar
  24. Caturegli  P, Asanovich  KM, Walls  JJ, Bakken  JS, Madigan  JE, Popov  S, ankA: an Ehrlichia phagocytophila group gene encoding a protein antigen with ankyrin-like repeats. Infect Immun. 2000;68:527783. DOIPubMedGoogle Scholar
  25. Herron  MJ, Nelson  CM, Larson  J, Snapp  KR, Kansas  GS, Goodman  JL. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science. 2000;288:16536. DOIPubMedGoogle Scholar
  26. Park  J, Choi  K-S, Dumler  JS. Major surface protein 2 (Msp2) of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun. 2003;71:401825. DOIPubMedGoogle Scholar
  27. Webster  P, IJdo  JW, Chicoine  LM, Fikrig  E. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J Clin Invest. 1998;101:193241. DOIPubMedGoogle Scholar
  28. Scorpio  DG, Caspersen  K, Ogata  H, Park  J, Dumler  JS. Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol. 2004;4:1. DOIPubMedGoogle Scholar
  29. Park  J, Kim  KJ, Choi  KS, Grab  DJ, Dumler  JS. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell Microbiol. 2004;6:74351. DOIPubMedGoogle Scholar
  30. Dumler  JS, Trigiani  ER, Bakken  JS, Aguero-Rosenfeld  ME, Wormser  GP. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol. 2000;7:68.PubMedGoogle Scholar
  31. Martin  ME, Caspersen  K, Dumler  JS. Immunopathology and ehrlichial propagation are regulated by interferon gamma (IFNγ) and interleukin-10 (IL-10) in a murine model of human granulocytic ehrlichiosis (HGE). Am J Pathol. 2001;158:18818. DOIPubMedGoogle Scholar
  32. Klein  MB, Hu  S, Chao  CC, Goodman  JL. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J Infect Dis. 2000;182:2005. DOIPubMedGoogle Scholar
  33. Akkoyunlu  M, Malawista  SE, Anguita  J, Fikrig  E. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun. 2001;69:557788. DOIPubMedGoogle Scholar
  34. Carlyon  JA, Abdel-Latif  D, Pypaert  M, Lacy  P, Fikrig  E. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect Immun. 2004;72:477283. DOIPubMedGoogle Scholar
  35. Carlyon  JA, Chan  WT, Galan  J, Roos  D, Fikrig  E. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J Immunol. 2002;169:700918.PubMedGoogle Scholar
  36. Choi  K-S, Dumler  JS. Early induction and late abrogation of respiratory burst in A. phagocytophilum–infected neutrophils. Ann N Y Acad Sci. 2003;990:48893. DOIPubMedGoogle Scholar
  37. Ge  Y, Yoshiie  K, Kuribayashi  F, Lin  M, Rikihisa  Y. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell Microbiol. 2005;7:2938. DOIPubMedGoogle Scholar
  38. Choi  K-S, Garyu  J, Park  J, Dumler  JS. Diminished adhesion of Anaplasma phagocytophilum–infected neutrophils to endothelial cells is associated with reduced leukocyte surface selectin expression. Infect Immun. 2003;71:458694. DOIPubMedGoogle Scholar
  39. Choi  KS, Grab  DJ, Dumler  JS. Anaplasma phagocytophilum infection induces protracted neutrophil degranulation. Infect Immun. 2004;72:36803. DOIPubMedGoogle Scholar
  40. Garyu  JW, Choi  KS, Grab  DJ, Dumler  JS. Defective phagocytosis in Anaplasma phagocytophilum–infected neutrophils. Infect Immun. 2005;73:118790. DOIPubMedGoogle Scholar

Main Article

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.